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Abstract 
The importance of the β-amino nitroalkanes is due to their high versatility allowing a 
straightforward entry to a variety of nitrogen-containing chiral building blocks; 
furthermore obtaining them in enantiopure  form allows their use in the synthesis of 
biologically active compounds or their utilization as chiral ligands for different uses. In 
this work, a reaction for obtaining enantiopure β-amino nitroalkanes  through asymmetric 
organocatalysis has been developed. The synthetic strategy adopted for the obtainment of 
these compounds was based on an asymmetric reduction of β-amino nitroolefins in a 
transfer hydrogenation reaction, involving an Hantzsch ester as hydrogen source and a 
chiral thiourea as organic catalyst. After the optimization of the reaction conditions over 
the  β-acyl-amino nitrostyrene, we tested the reaction generality over other aromatic 
compound and for Boc protected substrate both aromatic and aliphatic. A scale-up of the 
reaction was also performed. 
 
Riassunto 
L’importanza dei β-ammino nitroalcani è dovuta alla loro elevata versatilità in quanto 
consentono un accesso diretto a diversi building blocks contenenti azoto; inoltre il loro 
ottenimento in forma enantiopura consente di utilizzarli nella sintesi di composti 
biologicamente attivi o di essere usati come leganti chirali per svariati usi. Nel mio 
lavoro di tesi magistrale ho sviluppato una reazione per l’ottenimento di β-ammino 
nitroalcani enantiopuri attraverso la tecnica dell’organo-catalisi asimmetrica. La strategia 
adottata per l’ottenimento di questi composti è stata quella della riduzione di β-ammino 
nitroolefine attraverso una reazione di transfer hydrogenation, utilizzando un estere di 
Hantzsch come fonte di idrogeno ed una tiourea chirale come organo-catalizzatore. In 
seguito all’ottimizzazione delle condizioni di reazione fatta sul β-acil-ammino nitro-
stirene si è studiata la generalità della reazione per altri substrati aromatici e per substrati 
Boc protetti sia aromatici che alifatici. Si è inoltre provato uno scale-up della reazione. 
  
 
 
II 
 
Table of contents 
1. Introduction……………………………………………………...……………………1 
1.1. β-Amino Nitroalkanes: useful synthetic building blocks………………….………1 
1.2. Enantioselective/Asymmetric Catalysis………………………………...…………4 
1.2.1. Hydrogen Bonding Catalysis………………………………………..……….5 
1.3. Different Routes to Chiral β -Amino Nitroalkanes………………………….…......7 
1.3.1. Aza-Henry (or Nitro-Mannich) Asymmetric Reaction…………………..…..7 
1.3.2. Aza-Michael Asymmetric Reaction ...………………………………...……11 
1.3.3. Asymmetric Reduction of β-Amino nitroolefins……………………..…….13 
2. Aim of the project……………………………………………………………………15 
3. Results and Discussion………………………………………………………………17 
3.1. Synthesis of (Z)-N-(2-nitro-1-phenylvinyl)acetamide………………………..….17 
3.2. Synthesis of Racemic Product 4a……………………………………………...…17 
3.3. Optimization of the reaction conditions…………………………………….…....18 
3.4. Scope of the Reaction…………………………………………………………….21 
3.4.1. Aromatic Rings substituted β-acetylamino Nitroolefins…………...……….21 
3.4.2. Tert-Butyloxycarbonyl Protecting  β-Amino Nitroolefins…………...……..22 
3.4.3. Reaction with α-substituted β-Amino Nitroolefin………………….....……25 
3.5. Determination of the Absolute Configuration of the β-amino Nitroalkanes...…...26 
3.6. Proposed mechanism for the Transfer Hydrogenation………………………...…27 
4. Conclusion……………………………………………………………………………28 
5. Experimental Section………………………………………………………………..29 
5.1.General Methods…………………………………………………………………..29 
5.2.Materials…………………………………………………………………...….…..29 
5.3. Procedures to Obtain the Protected β-Amino Nitroolefins………………..……..30 
5.3.1 Typical rocedure for the preparation of β-Aryl substituted nitroolefins…...30 
5.3.2. Typical procedure for the preparation of β-Alkyl substituted 
Nitroolefins…………………………………………………………………….….30 
5.3.3. General procedure for the synthesis of β-amino nitroolefins….…………..32 
5.3.4. General procedure for the synthesis of β-acylamino nitroolefins….……...33 
5.3.5. General procedure for the synthesis of β-t-butyloxycarbonylamino 
nitroolefins…………………………...……………………………………………35 
5.4. Procedure for the Synthesis of Hantzsch ester 5b………………………...……...39 
5.5. General procedure for the synthesis of racemic β-amino nitroalkanes 4…………40 
5.6. General Procedure for the Asymmetric Transfer Hydrogenation………………...41 
5.7. Determination of the absolute configuration of the β-amino nitroalkanes…...…..52 
5.8. 1H-NMR spectra of products 4a and 4f……….………….....……………………53 
6. Bibliography………………………………………………………………………….54 
 
 
1 
 
1. Introduction 
1.1 β-Amino Nitroalkanes: useful synthetic building blocks 
Enantiomerically pure β-amino nitroalkanes are versatile intermediates in organic 
synthesis, because the two nitrogenated functions are present in different oxidation states, 
thus giving access to further transformations with complete chemoselectivity. β-
nitroamines can easily be converted into a variety of useful compounds1 such as α-amino 
acids2 and 1,2-diamines.3 
α-amino acids: Amino acids are biologically important organic compounds containing 
amine (-NH2) and carboxylic acid (-COOH) functional groups, usually along with a side-
chain specific to each amino acid. In biochemistry, amino acids having both the amine 
and the carboxylic acid groups attached to the first (alpha-) carbon atom have particular 
importance. They are known as α-amino acids (generic formula H2NCHRCOOH in most 
cases, where R is an organic substituent known as a "side-chain"). They include the 23 
proteinogenic ("protein-building") amino acids, which combine into peptide chains 
("polypeptides") to form the building-blocks of a vast array of proteins. These are all L-
stereoisomers. Because of their biological significance, amino acids are important in 
nutrition and are commonly used in nutritional supplements, fertilizers, and food 
technology. Industrial uses include the production of drugs, biodegradable plastics, and 
chiral catalysts. α-Amino acids can be easily obtained from β-amino nitroalkanes through 
the Nef reaction using a buffered permanganate solutions (pH=11) that can oxidise 
primary nitroalkanes into alkanoic acids without affecting other functions such as esters, 
amides, primary alcohols and acetals.2  
 
1,2-diamines: compounds incorporating the 1,2-diamine functionality are currently the 
topic of studies conducted in several fields. For instance, in recent years several synthetic 
diamine derivatives have been employed as medicinal agents, in particular in 
chemotherapy (e.g. platinum 1,2-diamino complexes). Chiral, enantiomerically pure 1,2-
diamines (or vicinal diamines) and their derivatives are also used increasingly in 
stereoselective organic synthesis, for example as chiral auxiliaries, or as metal ligands in 
catalytic asymmetric synthesis. For these reasons, the development of synthetic methods 
for the preparation of aliphatic 1,2-diamines in diastereomerically and enantiomerically 
pure form3 is an important task. 1,2-Diamines can be obtained by reducing the nitro 
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group of β-amino nitroalkanes; there are several procedures for the reduction of nitro 
compounds to amines; one of this methods, applicable to the reduction of both aromatic 
and aliphatic nitro compounds, concern the use of ammonium formate in the presence of 
Pd/C.1 
β-amino nitroalkanes are also precursors of other interesting compounds like 
monoamines,4 α-aminocarbonyls and glycosamines;5 
Moreover, the alkylation of β-amino nitroalkanes with alkyl halides and the Henry 
reaction with aldehydes enable the facile preparation of a myriad of structurally diverse 
and complex molecules bearing two or three stereocenters (Scheme 1).  
The most convenient way to obtain these useful enantiomerically pure building block is 
to use enantioselective catalysis as a synthetic tool. 
 
 
Scheme 1. Conversion of β-amino nitroalkanes into other compounds.  
Many of the described compounds are key structural element and they are present in 
biologically active molecules and pharmaceuticals (Figure 1) such as 
Clopidogrel 6 (an oral thienopyridine-class antiplatelet agent used to inhibit blood clots 
in coronary artery disease, peripheral vascular disease, cerebrovascular disease, and to 
prevent myocardial infarction and stroke);  
Oseltamivir7 (marketed under the trade name Tamiflu, an antiviral medication used to 
treat influenza A and influenza B (flu), and to prevent flu after exposure);  
Asimadoline 8 (acts as a peripherally selective κ-opioid receptor (KOR) agonist, and has 
been researched as a possible treatment for irritable bowel syndrome, with reasonable 
efficacy seen in clinical trials.);  
CP-690,550 9 (a drug of the janus kinase (JAK) inhibitor class; marketed as Xeljanz and 
Jakvinus, it is currently approved for the treatment of rheumatoid arthritis (RA) in the 
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United States and other countries. It has demonstrated effectiveness in the treatment of 
psoriasis. It is being studied for treatment of inflammatory bowel disease, and other 
immunological diseases, as well as for the prevention of organ transplant rejection.); 
Valsartan10 (trade name Diovan, is an angiotensin II receptor antagonist, that is selective 
for the type I (AT1) angiotensin receptor. Valsartan is mainly used for treatment of high 
blood pressure, congestive heart failure, and to increase the chances of living longer after 
a heart attack.) 
 
Figure 1.  key structural elements in chiral pharmaceuticals. 
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1.2 Enantioselective/Asymmetric Catalysis 
The enantioselective production of compounds is a central theme in current research. The 
broad utility of synthetic chiral molecules as single-enantiomer has made asymmetric 
catalysis a prominent area of investigation. 
Until few years ago, it was generally accepted that transition-metal complexes and 
enzymes were the two main classes of very efficient asymmetric catalysts. A change in 
perception has occurred during the last few years, when several reports confirmed that 
relatively simple organic molecules could be highly effective enantioselective catalysts 
of a variety of fundamentally important transformations. Organocatalyst not only have 
ease of manipulation and a green advantage, but also can be very efficient catalysts. This 
rediscovery has initiated an explosive growth of research activities in organocatalysis, 
both in industry and in academia.  
Thus, the use of pure organic catalysts turned out to be an additional efficient tool for the 
synthesis of chiral building blocks besides the well-established asymmetric metal-
complex-catalysed syntheses and biocatalysis.  
The organocatalysts can be classified by means of their interactions with the substrate or 
“mode of action” as covalent or noncovalent catalysts (Figure 2). 
 
Figure 2. General classification of the activation mode of  representative classes of molecules in 
organocatalysis. 
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In covalent organocatalysis, a new covalent bond between the catalysts and the substrate 
is formed as in the case of aminocatalysis and carbenes, leading to a strong interaction 
between the substrate and the reagent in the reaction. In the case of noncovalent 
interactions between the substrate and the catalyst, the activation of the substrate occurs 
via weak binding exemplified by hydrogen bonding or ionic interaction as in the case of 
phase transfer catalysis.11 
 
1.2.1. Hydrogen Bonding Catalysis  
This ubiquitous interaction is one of the central forces in Nature; the unusual and 
complex properties of bulk water, the ability of proteins to fold into stable three-
dimensional structures, the fidelity of DNA base pairing, and the binding of ligands to 
receptors are among the manifestations of this ubiquitous noncovalent interaction. 
Hydrogen bonds are feeble and quite easy to break, however when acting together they 
become much stronger and lean each other; this phenomenon is called “cooperativity”. 
Hydrogen bonding to an electrophile serves to decrease the electron density of this 
species, activating it toward nucleophilic attack. This principle is employed frequently by 
Nature's catalysts, enzymes, for the acceleration of a wide range of chemical processes. 
Recently, organic chemists have begun to appreciate the potential offered by hydrogen 
bonding as a mechanism for electrophile activation in small molecule, synthetic catalyst 
systems. In particular, chiral hydrogen bond donors have emerged as a broadly applicable 
class of catalysts for enantioselective synthesis.12  
 
The discovery that Schiff bases a–c (Figure 3) catalyze asymmetric hydrocyanation 
reactions of a wide variety of imine substrates13 revealed for the first time that chiral urea 
and thiourea derivatives are capable of mediating highly enantioselective 
transformations. 
 
 
Figure 3. Urea and thiourea Schiff bases. 
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These compounds had been designed originally as potential ligands for Lewis acidic 
metals, afterwards a higher enantioselectivity was observed in the absence of metal 
additives. Several factors may contribute to the special behavior of these species. The 
presence of electron-withdrawing groups serves to decrease the pKa of the N-H bonds, 
increasing their H-bond donating ability. The choice of urea or thiourea provides a 
method for altering H-bond-donating ability, while variation of the nitrogen substituents 
permits a high degree of fine-tuning of catalyst steric and electronic properties. Their 
structures also lend themselves readily to the preparation of bifunctional catalysts, using 
amine coupling partners incorporating additional acidic or basic groups. This approach 
has resulted in further expansion of the scope of this catalyst class.13  
Since 2001 research groups worldwide (e.g., Jacobsen, Nagaswa, Takemoto, Ricci, 
Connon) have realized the potential of thiourea derivatives and developed various 
achiral/chiral mono- and bifunctional derivatives (Figure 4) incorporating the electron-
poor 3,5-bis(trifluoromethyl)phenyl substrate-"anchor" functionality. A broad variety of 
monofuctional and chiral double hydrogen-bonding (thio)urea organocatalysts have been 
developed to accelerate various synthetically useful organic transformations employing 
H-bond accepting substrates, e.g., carbonyl compounds, imines, nitroalkenes as the 
starting materials. The research towards the design and implementations of these 
catalysts in organic synthesis is still in the focus of interest.14  
 
 
Figure 4. Structures of various thiourea derivatives. 
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1.3. Different Routes to Chiral β -Amino Nitroalkanes 
To date, the preparation of chiral β-amino nitroalkanes can be performed with different 
asymmetric reactions. 
1.3.1. Aza-Henry (or Nitro-Mannich) Asymmetric Reaction 
The aza-Henry (nitro-Mannich) reaction,15 that is, nucleophilic addition of nitroalkanes 
to imines, is a useful carbon-carbon bond-forming process in organic chemistry. 
Although this reaction has been known for over a century, real interest from the synthetic 
community only began around the turn of the century and has since received 
considerable attention. This resulted in rapid development of a wide range of novel 
methodologies. Interest in the nitro-Mannich reaction arises from the value of the 
synthetically versatile β-Amino Nitroalkanes products. 
The first example of an asymmetric direct metal-catalyzed nitro-Mannich reaction was 
reported by Shibasaki et al. in 1999.16 They used the Yb/K heterobimetallic complex, 
which contains both Lewis-acidic and Brønsted-basic sites, for reaction between 
nitromethane and a variety of N-phosphinoyl-aryl imines (Scheme 2). The catalyst 
successfully promoted nitro- Mannich reaction in good enantioselectivities; however, the 
catalyst failed to promote reaction of higher homologues of nitromethane, such as 
nitroethane. 
 
Scheme 2. Aza-Henry Reactions Catalyzed by Yb/K/binaphthoxide Catalyst. 
In 2001, Jørgensen published the first asymmetric nitro-Mannich reactions of TMS-
nitronates with ethylglyoxylate-N-PMP-imine17  (Scheme 3). They used Cu(II)−cis-DiPh-
BOX catalyst  to achieve excellent yields and enantio- and diastereoselectivities. 
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Scheme 3. Asymmetric Lewis-Acid-Catalyzed indirect Nitro-Mannich Reaction. 
In 2006 Palomo also described the use of complexes of ZnII and N-methylephedrine as 
catalysts of the reaction of nitromethane and N-Boc aryl imines,18 thus providing a new 
entry to give N-Boc β-nitroamines in generally with good yields and with high levels of 
stereocontrol. 
 
 
Scheme 4. Enantioselective Aza-Henry Assisted by ZnII and N-Methylephedrine (MS = molecular sieves). 
 Several drawbacks of the reactions catalyzed or promoted by metal salts may lie in the 
cost and the toxicity of the metal species. The first asymmetric organocatalyzed nitro-
Mannich reaction was reported by the group of Takemoto in 2004.19 The group applied 
Takemoto’s bifunctional thiourea catalyst, to the reaction of nitromethane and a range of 
N-phosphinoyl-aryl imines (Scheme 5). The reactions were high yielding but only gave 
moderate enantioselectivities. Only a single diastereoselective example was given using 
nitroethane to form the product in a modest 3:1 dr in favor of the anti diastereomer. 
 
 
Scheme 5. First Asymmetric Organocatalytic Aza-Henry Reaction. 
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In 2005, Jacobsen et al. found a new thiourea catalyst that promoted the addition of a 
range of nitroalkanes to N-Boc-aryl-imines, affording both excellent yields and 
enantioselectivities (Scheme 6).20 
 
 
Scheme 6. Jacbsen’s Thiourea-Catalyzed Aza-Henry Reactions (DIPEA = N,N-Diisopropylethylamine). 
Since the reports by Takemoto19 and Jacobsen20 on the application of thiourea-based 
organocatalysts to asymmetric nitro-Mannich reactions, there have been a large number 
of publications from other groups demonstrating the use of thioureas bearing various 
chiral scaffolds. These include catalyst-derived structures including from cinchona 
alkaloids, 21 chiral sulfonamides,22 glycosides,23 and steroids. 
One of the most efficient organocatalytic nitro-Mannich protocols reported to date was 
presented by C. Wang et al. in 2008.24 They used a chiral thiourea to catalyze the nitro-
Mannich reaction between a range of N-Boc-aryl-imines and a number of nitroalkanes 
(Scheme 7). Near quantitative yields were obtained in the majority of cases, accompanied 
by exceptional stereoselectivities. 
 
 
Scheme 7. Wang’s Thiourea Catalyzed Aza-Michael Reactions. 
The β-amino-alkyl nitroalkanes are difficult to obtain with the Aza-Henry reaction since 
the N-carbamoyl imines derived from aliphatic enolizable aldehydes readily tautomerize 
to the corresponding ene carbamate. To overcome these drawbacks, in 2005, Bernardi et 
al. developed a new approach to the asymmetric addition of nitromethane to N-
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carbamoyl imines generated in situ from α-amido sulfones25 (scheme 8); the reaction is 
catalyzed by a simple quininium salt (a chiral phase transfer catalyst), which first 
promotes the formation of the imines, and then activates the nucleophile for asymmetric 
addition. This method allows the use of N-carbamoyl imines derived from enolizable 
aldehydes in a catalytic asymmetric aza-Henry reaction, thus extending the generality of 
this asymmetric transformation. 
 
Scheme 8. Phase-Transfer-Catalyzed Aza-Henry Reaction Using Imines Generated In Situ. 
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1.3.2. Aza-Michael Asymmetric Reaction 
Consisting in the conjugate addition of nitrogen-based nucleophiles to Michael acceptors, 
the Aza-Michael reaction is an efficient C-N bond forming reactions of significant 
interest in organic chemistry. Considering that stereogenic centers containing C-N bonds 
are present in many important biomolecules, in recent years the development of efficient 
stereoselective Aza-Michael26 has attracted considerable attention. In particular, the 
addition of ammonia equivalents to nitroalkenes gives rise to the synthetically interesting 
β-amino nitro functionality. 
 
The first example of asymmetric Aza-Michael was published by Jørgensen et al. in 
1996.27 The reaction is catalysed by titanium complexes such as TiX2–TADDOLate and 
TiCl2–BINOLate and good conversions with enantiomeric excesses up to 42% were 
obtained with the application of 10 mol% of the catalyst. 
Since then, a number of chiral catalyst systems for this reaction have been developed. 
The first asymmetric organocatalytic aza-Michael addition to nitroalkenes was 
demonstrated in 2006 by Wang et al.,28 employing aromatic heterocyclic benzotriazoles 
as nitrogen centered nucleophiles; the process is promoted by a cinchona alkaloid 
derivative to give Michael adducts in moderate to high enantioselectivities. However, the 
synthetic applicability of the products are limited. 
 
Sheme 9. First Asymmetric Organocatalytic Aza-Michael Reaction. 
In 2009, Ooi et al.29 reported the aza-Michael addition of 2,4-dimethoxyaniline to 
nitroalkenes in excellent yields and enantioselectivities by Brønsted-acid catalysis using 
chiral arylaminophosphonium barfates. A minor drawback is that 2.5 equivalents of CAN 
(cerium ammonium nitrate) were required for deprotection to afford the primary amine. 
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R
NO2 +
MeO OMe
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R
HN
MeO OMe
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BArF-Catalyst
(2 mol %)
Toluene, -15°C
N
N
P
N
N
H
Ar
Ar
H
H H
[BArF4]
-
R = aryl: 89-99% yield, 91-97% ee
R = alkyl: 93-98% yield, 86-87% ee BArF-Catalyst  
Scheme 10.  Aza-Michael Reaction Catalized by Chiral Arylaminophosphonium Barfates Catalyst         
(Ar = 3,4,5-F3-C6H2; BArF = (3,5-(CF3)2-C6H3)4B
- ). 
In 2010, Jorgensen et al. 30 reported the formal addition of ammonia to nitroalkenes 
affording optically active β-amino nitro compounds in high yields and 
enantioselectivities. The approach is based on a thiourea-catalyzed aza-Michael reaction, 
by which benzophenone imine serves as a masked ammonia equivalent, which is released 
by one pot hydrolysis.  
 
Scheme11. Jacbsen Type Thiourea Catalyzed Aza-Michael Reaction. 
In 2011 Maruoka et al.31 developed a highly efficient catalytic asymmetric amination of 
nitroolefins under neutral phase-transfer conditions with the influence of a chiral 
bifunctional tetraalkylammonium bromide in biphasic solvent. 
 
 
Scheme 12. Asymmetric Neutral Amination Catalyzed by Chiral Ammonium Salts. 
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1.3.3. Asymmetric Reduction of β-Amino nitroolefins 
The asymmetric catalytic reduction of β-amino nitroolefins constitutes a complementary 
straightforward pathway to form chiral β-amino nitroalkanes, owing to the easy 
availability of starting materials.  
In this context, in 2012, J. Sun et al.32 reported the asymmetric hydrosilylation of β-p-
methoxyphenylamino nitroolefins using 10 to 20 mol % of a simple N-sulfinyl urea as a 
bifunctional catalyst and 3 equivalent of trichlorosilane (a reagent not very easy to handle 
due to its volatility, toxicity and corrosivity) (Scheme 13). β-Amino nitroalkanes with 
good to high enantioselectivities (79-97% ee) were obtained. 
 
 
Scheme 13. Asymmetric hydrosilylation of β-p-methoxyphenylamino nitroolefins (PMP= p-
methoxyphenyl). 
More recently, enantioselective metal catalysed asymmetric hydrogenations13 of β-
acylamino nitroolefins have been developed.  
In 2013, Wang and Zhang33 used a Rh–Tangphos complex achieving high 
enantioselectivities for β-aryl β-amino nitroalkenes (up to 93% ee) but rather poor 
enantioselectivity for alkyl substrates (only 18–22% ee) (Scheme 14). 
 
 
Scheme 14. Asymmetric Hydrogenation of β-Acylamino Nitroalkenes with Rh Complex (COD= 1,5-
cyclooctadiene). 
Afterward, in 2014 Hou et al.34 reported an highly efficient enantioselective 
hydrogenation of β-acylamino nitroolefins successfully accomplished employing an Ir-
spiroPhos complex in 20 atm H2 and 80 °C condition; very high yields and excellent 
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enantioselectivities were achieved with both aryl and alkyl β-amino nitroalkenes 
(Scheme 15). 
Scheme 15. Asymmetric Hydrogenation of Β-Acylamino Nitroalkenes with Ir Complex. 
 
Very recently, Hu, Dong and Zhang35 developed the highly efficient asymmetric 
hydrogenation of β-amino nitroolefins catalyzed by rhodium/bis(phosphine)-thiourea L1 
complex with excellent enantioselectivities (in S enantiomer) and yields (up to 96% ee, 
96% yield, >99% conversion, TON up to 1000) (Scheme 16). 
 
 
Scheme 16. Asymmetric Hydrogenation of Β-Acylamino Nitroalkenes with Rh/Bis(Phosphine)-Thiourea 
Complex (NBD= 2,5-norbornadiene). 
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2. Aim of the project 
My apprenticeship activity was based on the development of an organocatalyzed 
enantioselctive reduction of β-amino nitroolefins in a transfer hydrogenation reaction, a 
reaction in which the hydrogen source is a molecule different from H2. As we have seen 
in the previous paragraph, the different types of reaction for the reduction of β-amino 
nitroolefins that have been proposed to date, are based on the utilization of metal 
complex catalysts33-35 or a hydrosilylation reaction as reported by J. Sun et al.32 The 
choice of operating with a transfer hydrogenation reaction is in line with the 
organocatalysis principles; indeed, this method avoids hazardous high pressures of H2 
gas with the relative experimental setups.  
In Nature, transfer hydrogenation processes are very frequent, and are typically mediated 
by the dihydropyridine-containing cofactor NADH (nicotinamide adenine dinucleotide) 
or by its phosphate analogue NADPH, associated with enzymes. Aromatisation to the 
corresponding pyridine (NAD+ or NADP+) is the thermodynamic driving force 
promoting the hydride transfer. Analogous to Nature’s NADH, Hantzsch esters (HE) 
(Fig. 7) have been shown to serve the role of small molecule NADH analogues given that 
the dihydropyridine system participates in hydride delivery with electrophilic π-systems 
in a variety of non-catalytic processes. Also due to their rapid synthetic access, HE have 
served as a powerful platform for the development of a large number of reductive 
organocatalytic processes in the last few years, and perhaps represent the most successful 
and broadly applied example of a bioinspired catalytic manifold.36 
 
Figure 7. a) NADH: R= H; NADPH: R= PO3
2-. b) Hantzsch ester structure. 
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Following the previous experience of the research group in this field,37 we decided to use 
the Hantzsch ester as hydrogen source for the development of an organocatalytic 
enantioselective reduction of β-amino nitroalkenes. 
Discover a metal-free catalyst able to perform the reaction of asymmetric reduction with 
a good conversion and good enantioselectivity is the first target of this project. The 
organocatalyst considered are thioreas for their capacity to activate the nitro compounds. 
The model reaction taken into consideration, as for the previous analogous work utilizing 
metal complexes,33-35 is the reaction of the reduction of (Z)-N-(2-nitro-1-
phenylvinil)acetamide (Scheme 17).  
 
Scheme 17. Model reaction taken into consideration for the asymmetric reduction reaction.  
After finding a catalyst with a promising reactivity, the targets will be: 
 Optimizing the reaction conditions to reach the best conversion and 
enantioselection for this reaction. Among the parameters that we could change 
there are: temperature, reaction time, R substituent of HE, solvent, catalyst load. 
 Test the reaction with a different protecting group, such as tert-butyloxycarbonyl 
(Boc) as it is considered one of the most useful protecting group and the most 
widely used in synthetic organic chemistry when it is required to protect primary 
or secondary amines. This utility is mainly due to the easiness of its introduction 
and removal and to its orthogonality with many other protecting groups.38 
 Study the generality of the reaction introducing substituents of different nature 
over the aromatic ring of the nitroalkene. 
 Test the reaction with aliphatic nitroolefins, since this kind of nitrolefins represent 
challenging substrates. 
 Conducting the reaction with a substrate having an α-substituent with respect to 
the nitro group, for achieving the formation of two stereo centers. 
 Determining the absolute configuration of the obtained stereocenter. 
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3. Results and Discussion 
3.1. Synthesis of (Z)-N-(2-nitro-1-phenylvinyl)acetamide 
We started from the synthesis of the (Z)-N-(2-nitro-1-phenylvinyl)acetamide; to obtain 
this compound we proceeded with the amination of β-nitrostyrene with methoxylamine in 
dimethylformamide (DMF); the addition of the methoxylamine to nitrostyrene provided 
the intermediate 1a in quantitative yield, and the subsequent treatment of 1a with two 
equivalent of base (potassium tert-butoxide) furnished product 2a (Scheme 18). 
 
Scheme 18. Amination of Nitrostyrene. 
Next, we protected the amino moiety with an acetyl group by treating 2a with acetic 
anhydride in the presence of triethylamine. The reaction was conducted in toluene at 
45°C overnight (Scheme 19) and the pure β-acetylamino nitroolefin 3a was obtained 
after column chromatography. 
 
Scheme 19. Protection of the amino group. 
3.2. Synthesis of Racemic Product 4a 
With the β-acetylamino nitrostyrene 3a in hand, we started with the preparation of the 
racemic product 4a by reducing the olefin’s double bound with sodium borohydride 
(NaBH4) in methanol (MeOH) (Scheme 20). The racemic mixture was injected in a chiral 
stationary phase HPLC to separate the two enantiomers, in order to have a reference to 
measure the enantiomeric excess (ee) of the asymmetric reaction. 
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Scheme 20. Racemic Reduction of the Compund 3a. 
3.3. Optimization of the reaction conditions 
We started to test the transfer hydrogenation of 3a with Hantzsch ester 5a as hydrogen 
donor with three different chiral thioureas in p-xylene at 60 °C (Scheme 21). 
Takemoto’s catalyst (cat 1), Ricci’s catalyst (cat 2) and a Jacobsen type thiourea (cat 3), 
afforded product 4a in a 8%, 50% and 90% conversion respectively (Scheme 21) and 
with an enantiomeric excess (ee) of 60% and 94% respectively (the ee of the reaction 
with cat 1 was not determined because of the low conversion).  
 
Scheme 21. Chiral Thioureas Tested for the Enantioselective Transfer Hydrogenation. 
Satisfied with the result obtained with the cat. 3, we started to study this reaction with the 
aim of optimizing the reaction conditions in term of conversion and enantiomeric excess. 
All the reactions have been performed in a screw cap round bottom vial to prevent the 
oxidation of the Hantzsch ester. We have observed that opening the vial and sampling the 
mixture with the aim of checking the conversion, stopped the reaction probably for the 
complete oxidation of the HE. For this reason, all the test reactions performed for 
evaluating the conversion and the ee at different conditions were performed without 
opening the vials till the end. 
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We observed that the use of the Hantzsch ester 5b with tert-butyl substituents at the ester 
functionality afforded better result in term of conversion with respect to 5a. A catalyst 
loading of 5 mol% was also well tolerated (compare entries 1-3 in table 1). Moreover 
increasing the temperature to 60 °C (entries 4,5) the possibility of using a 5 mol% of 
catalyst was confirmed with a promising 80% of conversion. Extending the reaction time 
to 14 h (entry 6), the conversion reached 90% yet with a small erosion of the ee. Next the 
concentration of the reaction mixture was increased to 0.3M (entry 7), obtaining a 
complete conversion of 3a and a very high ee. A further decrease of the catalyst loading 
(compare entries 7, 8 and 9) gave a slight lower enantioselectivity of the product 4a. 
Table 1. Optimization of the Reaction Conditions in the Asymmetric Reduction of 3a.a) 
 
Entry HE (eq) Cat.3 (mol%) p-Xylene (M) T (°C) t (h) Conv. (%)b) ee (%)c) 
1 5b (1.15) 15 (0.1M) r.t. 4:10 66 / 
2 5a (1.15) 10 (0.1M) 60  3:40 37 / 
3 5b (1.1) 5 (0.1M) 60  2:15 70 / 
4 5b (1.15) 10 (0.1M) r.t. 5:30 85 98 
5 5b (1.15) 5 (0.1M) 60  5:30 80 98 
6 5b (1.2) 5 (0.1M) 60  14 90 92 
7 5b (1.2) 5 (0.3M) 60  14 100 97 
8 5b (1.2) 2.5 (0.3M) 60  14 96 90 
9 5b (1.2) 1 (0.3M) 60  14 94 90 
a) Reactions performed over 0.05 mmol of 3a b) Determined on the crude mixture by 1H NMR analysis. c) Determined 
by chiral stationary phase HPLC. 
Next a solvent screening was performed as reported in Table 2. Both toluene and 
benzotrifluoride furnished excellent results at 60°C (compare entries 1-3). DCM was 
tested both at 40 °C and at r.t. affording 4a with a good conversions but a lower ee 
(entries 4,5). All the aromatic solvents were tested at r.t. achieving in the all the case a 
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single enantiomer of 4a (the second enantiomer was not visible in HPLC) but with a 
slightly lower conversions (entries 6-10).  
To conclude the screening reactions we performed three parallel tests in p-xilene, toluene 
and benzotrifluoride at 40°C for 14h (entries 11-13) and perfect results were obtained 
(conversion >99%, ee >99%). So we decided to go on with toluene as the solvent since is 
the less expensive and we adopted the conditions of entry 12 for the following reactions. 
Table 2. Optimization of the Reaction Conditions in the Asymmetric Reduction of 3a.a) 
 
Entry HE (1.2eq) Solvent (0.3M) T (°C) t (h) Conv. (%)b) ee (%)c) 
1 5b p-Xylene  60  14 >99 97 
2 5b  Toluene  60  14 >99 97 
3 5b  Benzotrifluoride 60  14 >99 97 
4 5b  DCM  40  14 >99 96 
5 5b  DCM  r.t. 14 97 96 
6 5b  p-Xylene  r.t. 14 93 99 
7 5b  Benzotrifluoride r.t. 14 91 >99 
8 5b  p-Xylene  r.t. 18 97 >99 
9 5b Toluene  r.t. 18 97 >99 
10 5b  Benzotrifluoride r.t. 18 97 >99 
11 5b  p-Xylene  40  14 >99 >99 
12 5b Toluene  40  14 >99 >99 
13 5b Benzotrifluoride 40  14 >99 >99 
a) Reactions performed over 0.05 mmol of 3a b) Determined on the crude mixture by 1H NMR analysis. c) Determined 
by chiral stationary phase HPLC. 
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3.4. Scope of the Reaction 
3.4.1. Aromatic Rings substituted β-acetylamino Nitroolefins 
With the optimized reaction condition in hand, we started to study the scope of the 
reaction. Different protected β-amino nitroolefins bearing aromatic rings substituted with 
either electron releasing and electron withdrawing groups have been synthesized starting 
from the corresponding nitroolefins in turn obtained from the related aldehydes and 
nitromethane. The synthetic sequence (Henry reaction with a subsequent dehydration) 
was performed in the presence of ammonium acetate and using nitromethane as solvent 
(Scheme 22).  
 
Scheme 22. General synthesis for substituted β-nitrostyrenes. 
After five hours of reflux, solvent extraction and purification (by recrystallization from 
ethanol or column chromatography), the nitroolefins have been obtained; subsequently 
this nitroolefins were aminated and protected following the methodology previously 
described for the amination and the acetyl protection of the nitrostyrene. The obtained β-
acetylamino aromatic nitroolefins are reported in figure 8. 
 
Figure 8. Aromatic Rings substituted β-acetylamino Nitroolefins. 
The transfer hydrogenation reaction was achieved with substrates 3b-3e, using the 
optimized condition affording the corresponding β-acetylamino nitroalkanes 4b-4e with 
excellent results, 89->99% conversion and 97->99% ee (Table 3). 
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Table 3. Scope of the Reaction with Aromatic β-Acetylamino Nitroolefins.a) 
 
 
 
 
 
a) Conditions: 3 (0.15 mmol), cat.3 (0.075 mmol, 5 mol%), 5b (0.18 mmol), 40 °C, 14 h. b) Determined on the crude 
mixture by 1H NMR analysis.  c) Pure product 4, isolated by chromatography on silica gel. d) Determined by chiral 
stationary phase HPLC. 
3.4.2. Tert-Butyloxycarbonyl Protected β-Amino Nitroolefins 
Established the robustness of the transfer hydrogenation involving aromatic β-
acetylamino nitroolefins, Hantzsch ester 5b and cat 3, we decided to try the reaction over 
Boc-protected β-amino nitroolefins. 
Boc-protect β-amino nitroolefins were obtained by reaction with 1.2 equivalents of di-t-
butyl dicarbonate in the presence of 0.05 equivalents of dimethylamino pyridine (DMAP) 
(Scheme 23).  
 
Scheme 23. Boc-Protection of General β-Amino Nitroolefins. 
The reaction with the Boc-protected nitroolefins 3f (figure 9) was accomplished with the 
optimized conditions, and we obtained a lower conversion (70%) compared to the 
analogous acetylated substrate, so we increased both the reaction time and the 
temperature. 
We decided to maintain the temperature at 40°C and to use a longer reaction time, paying 
attention to saturate the reaction’s vial with nitrogen; in fact in some tests the Hantzsch 
ester resulted completely oxidized, probably due to the atmospheric oxygen. The reaction 
in this re-optimized conditions afforded the product 4f in 95% conversion (90% yield) 
and complete enantioselection (entry 1 table 4).  
The transfer hydrogenation of 3f could also be performed on a larger scale (2 mmol, 
Table 4, entry 2) although with a small erosion in the yield (compare entries 1 and 2). 
Entry 3 Conv. (%)b)  Yield (%)c) ee (%)d) 
1 a >99 97 >99 
2 b 89 81 >99 
3 c >99 90 96 
4 d >99 94 97 
5 e 99 91 98 
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With the aim of enlarging the scope of the transfer hydrogenation, we synthesized a large 
series of Boc protected β-amino nitroolefins bearing both aromatic and aliphatic 
substituents. 
The aromatic nitroolefins were synthesized from the related aldehydes, using the 
methodology previously reported in scheme 22. Amination and Boc protection led to the 
various tert-butyloxycarbonyl aromatic β-amino nitroolefins (figure 9, product 3g-3l). 
Among this, substrates with a methyl group placed in the ortho, metha and para position 
of the aromatic ring (3j,k,l) have been synthetized to evaluate the influence of the 
substitution pattern on the benzene ring; a heteroaromatic one has been also synthesized 
(3i). 
 
 
Figure 9.  N-Boc β-amino Nitroolefins.  
 
 
To obtain the various aliphatic nitroolefins we started from the related aldehydes and 
nitromethane in the presence of potassium tert-butoxide; the β-nitroalcohols, obtained 
from the Henry reaction, were reacted in the presence of trifluoroacetic anhydride with 
the subsequent addition of triethylamine to afford the related β-aliphatic nitroolefins 
(Scheme 24).  
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Scheme 24. Synthesis β Aliphatic Nitroolefins  
 
After common work-up and purification operation, the β-aliphatic nitroolefins were 
aminated and Boc protected, following the same procedures of the aromatic ones, 
affording the nitroolefins 3m-q shown in figure 9. 
 
Compounds 3g-3l were reacted under the optimized conditions for the substrate 3f, 
(Hantzsch ester 5b as hydrogen donor in toluene at 40 °C for 18 hours) and the obtained 
results are reported in table 4.  
We observed that also using Boc as protecting group, the aromatic substrates with either 
electron donating or electron withdrawing substituents over the aromatic rings, as well as 
the heteroaromatic substrate 3i, were well tolerated, affording the corresponding N-Boc 
adducts 4g-j with very good conversions, yields and enantioselectivities, see the entries 
3-6. The reaction of derivative 3h (entry 4) was conducted at 20°C instead of 40°C, in 
this way we enhanced the ee from 93 to 96 without compromising the conversion value.  
 
Table 4. Scope of the Reaction with Aromatic N-Boc β-amino Nitroolefins..a) 
Entry 3 Conv. (%)b) Yield (%)c) ee (%)d) 
1 f 95 90 >99 
2e) f / 86 >99 
3 g 97 86 >99 
4f) h 95 93 96 
5 i 75 71 >99 
6 j 93 86 97 
7 k 95 75 >99 
8 l 50 40 98 
a) Conditions: 3 (0.15 mmol), cat.3 (0.075 mmol, 5 mol%), 5b (0.18 mmol), 40 °C, 18 h. b) Determined on the crude 
mixture by 1H NMR analysis.  c) Pure product 4, isolated by chromatography on silica gel. d) Determined by chiral 
stationary phase HPLC. e) On a 2.0 mmol scale. f) Reaction performed at 20 °C. 
Derivatives 4j–l could be obtained in 86–40% yields and with very good 
enantioselectivities (entries 6-8). Yields followed the order para>meta>ortho, indicating 
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a (not dramatic) sensitivity of the reaction to steric factors. Enantioselectivities remained 
always very high. 
Regarding the β-aliphatic nitroolefins, we started to test their reactivity in the optimized 
reaction conditions (table 2, entry 10); since we obtained poor conversions, respect to the 
aromatic substrates, with both 3m and 3n nitroolefins, we tried to change some reaction 
parameters such as: time and temperature, catalytic load and 5b equivalents. For both 3m 
and 3n, we reached the best conversion by reacting them at 60°C for 24 hours, with the 
same catalytic load, solvent and HE equivalents used for the aromatic nitroolefins.. We 
decided to react all the aliphatic nitroolenfins in the latter found condition, obtaining the 
excellent results shown in the table 5. 
 
Table 5. Scope of the Reaction with Aliphatic N-Boc β-amino Nitroolefins..a) 
 
 
 
 
 
 
 
 
a) Conditions: 3 (0.15 mmol), cat.3 (0.075 mmol, 5 mol%), 5b (0.18 mmol), 60 °C, 24 h. b) Determined on the crude 
mixture by 1H NMR analysis.  c) Pure product 4, isolated by chromatography on silica gel. d) Determined by chiral 
stationary phase HPLC. 
 
3.4.3. Reaction with α-substituted β-Amino Nitroolefin 
One of our initial aims was to synthesize an α-substituted substrate, that allow the 
possibility of forming two stereo centers in the H-transfer reaction and to evaluate the 
diastereoselectivity of the process. Accordingly, we synthetized the analogous α-
methylated of the substrate 3f. 
We reacted benzaldehyde with the nitroethane, and after the usual procedure of 
amination, ad Boc protection product 3r was obtained in about 40% yield. 
Next the tert-butyl (Z)-(2-nitro-1-phenylprop-1-en-1-yl)carbamate 3r was subjected to 
the optimized reaction conditions affording a mixture of two nearly enantiopure 
diasteroisomers (1S,2R)-4r and (1S,2S)-4r in a 2:1 ratio with complete conversion (88% 
yield) (Scheme 25). 
Entry 3 Conv. (%)b)  Yield (%)c) ee (%)d) 
1 m 91 91 98 
2 n 99 88 98 
3 o 89 60 96 
4 p >99 91 93 
5 q 97 92 97 
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Scheme 25. Transfer hydrogenation with the α-substituted substrate 3r. 
3.5. Determination of the Absolute Configuration of the β-amino 
Nitroalkanes 
The absolute configuration of products 4 was determined to be S by comparison with 
literature data (CSP-HPLC retention time and optical rotation [α]D value) for compound 
4a,39 4f,30,40 4n30,40 and 4o40 (Table 6). 
 
 
 
 
 
[α]D
 25 +73 (c 1, CH2Cl2); 
Lit [α]D
20 = -69.20 (c = 0.5, CH2Cl2), 99% ee (R) 
 
 
 
 
[α]D
 25 +29 (c 1, CH2Cl2); 
Lit [α]D
25 = -20.1(c 1.0, CHCl3), 91% ee (R) 
 
 
 
 
[α]D
 25 -15.5 (c 1, CH2Cl2); 
Lit [α]D
25 = +24 (c 1.0, CHCl3), 98% ee (R) 
 
 
 
[α]D
 25 -40 (c 1, CH2Cl2); 
Lit [α]D
25 = +26.4 (c 1.0, CHCl3), 97 % ee (R) 
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3.6. Proposed mechanism for the Transfer Hydrogenation 
Extensive mechanistic studies of the role of chiral thiourea catalysts related to cat.3, 
using kinetic, spectroscopic and computational work, have previously been performed, 
establishing its more stable conformations and mode of action.41 Building upon these 
studies and in line with the research group previous hypothesis37 and related calculation 
results,42 a tentative reaction model for the transfer hydrogenation reaction of β-amino 
nitroalkenes can be reasonably put forward (Scheme 26). This model implies the 
stabilization of the transition state of the reaction by coordination of the nitro group of 
nitroalkenes by the thiourea moiety, while the amide oxygen coordinates the Hantzsch 
ester at its NH proton, positively charged during the hydride-transfer step. Subsequent 
irreversible proton transfer step leads to the (S)-adducts 4 and the pyridine derivative 
with concomitant catalyst release. 
 
Schem 26. Proposed Reaction Model. 
The very high enantioselectivities obtained with the cat.3 with both the present β-amino-
and the previously reported37 β-trifluoromethyl nitroolefins remarks the reliability of this 
model and the good geometrical fit between the electrostatically complementary 
functionalities of the catalyst and a transition state leading to (S)-products. 
Moreover, the results reported in Scheme 25 suggest that the addition of the hydride at 
the carbon in β to the nitro group occurs with high enantioselectivity when the substrate 
is bound to the catalyst, while the addition of the proton occurs without any 
stereocontrol. The two diastereomers at the stereogenic centre α-to the nitro group are in 
fact generated in nearly equimolar amounts.  
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4. Conclusion 
In summary, we have developed a highly enantioselective organocatalytic transfer 
hydrogenation of β-acylamino and β-t-butyloxycarbonylamino nitroolefins 3 with a 
simple thiourea catalyst and Hantzsch esters as hydrogen source for the direct access to 
enantiomerically pure β-amino nitroalkanes. 
To reach this achievement we firstly identified cat.3 and HE 5b as the most promising 
catalyst and hydrogen source for the substrate 3a, then we optimized the reaction 
conditions until reaching a complete conversion and enantioselection with 5 mol% of 
catalyst, 1.2 equivalents of 5b, toluene as solvent, temperature of 40 °C in 14 hours of 
reaction. Excellent results were obtained for all the tested β-acylamino nitroolefins. 
After observing a promising reactivity with the Boc protected substrate 3f, a wide range 
of both aliphatic and aromatic Boc protected substrates have been synthetized. The 
reaction conditions were adjusted for both types of substrates; also in these cases the 
nitroalkanes products 4 have been obtained with good yields and excellent ee’s. 
Furthermore, with the substrate 3r we observed that the reaction did not furnish 
substantial diastereoselection in the formation of the second stereocentre. A scale up of 
the reaction has been successful completed utilizing 2 millimoles of the substrate 3f, 
obtaining the nitroalkane 4f with 86% yield and total enantioselection. 
This optimized methodology represent a valid alternative to the previously developed 
reduction of the β-amino nitroolefins affording the various nitroalkanes 4 with excellent 
results. 
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5. Experimental Section 
5.1. General Methods 
1H, 13C and 19F NMR spectra were recorded on a Varian AS 400 spectrometer. Chemical 
shifts (δ) are reported in ppm relative to residual solvent signals for 1H and 13C NMR,43 
and using CF3C6H5 as external reference calibrated at -63.72 ppm for 
19F NMR. 13C 
NMR spectra were acquired with 1H broad band decoupled mode. Data are reported 
either as: s = singlet, d = doublet, dd= double doublet, t = triplet, q = quartet, m = 
multiplet, br = broad, coupling constant(s) in Hz, integration. Mass spectra were recorded 
on a micromass LCT spectrometer using electrospray (ESI) ionisation techniques or by 
use of electronic impact ionization (EI+). Optical rotations were measured on a Perkin-
Elmer 241 polarimeter provided with a sodium lamp and are reported as follows: [α]T(°C) 
(c = g/100 mL, solvent). The enantiomeric excess (ee) of the products was determined by 
chiral stationary phase HPLC (Daicel Chiralpak AD-H and AS columns or Chiralcel OJ-
H and OD columns see below for further details), using a UV detector operating at 254 
nm. Chromatographic purifications were performed using 70-230 mesh silica. 
 
5.2. Materials 
Analytical grade solvents and commercially available reagents were used as received, 
unless otherwise stated. Hantzsch ester 2a44 and chiral thioureas 3a,c45 were prepared as 
reported in the literature. β-Aryl substituted nitroolefines46 and β-alkyl substituted 
nitroolefines47 were prepared from the corresponding freshly distilled aldehydes 
following literature procedures as described at page S2. (E)-(2-nitroprop-1-en-1-
yl)benzene was prepared following literature procedure.48 
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5.3. Procedures to Obtain the Protected β-Amino Nitroolefins 
5.3.1. Typical rocedure for the preparation of β-Aryl substituted nitroolefins46 
 
 
 
A stirred solution of the appropriate aldehyde (10 mmol) and ammonium acetate (190 
mg, 2.5 mmol) in nitromethane (50 mL) was heated at reflux for 5 h. The obtained 
solution was poured into water and extracted with diethyl ether (3 × 50 mL). The extract 
was washed with brine, dried over MgSO4, filtered and evaporated under reduced 
pressure. The residue was purified by recrystallization from ethanol or by silica gel 
column chromatography (hexanes/EtOAc, 20/1). 
 
5.3.2. Typical procedure for the preparation of β-Alkyl substituted nitroolefins47 
 
Potassium tert-butoxide (0.336 g, 3.0 mmol, 0.1 equiv) was added to a stirred solution of 
the appropriate aldehyde (30.0 mmol), nitromethane (2.44 mL, 45 mmol, 1.5 equiv), 
THF (7.5 mL), and tert-butanol (7.5 mL) at 0 °C. The stirred mixture was allowed to 
warm to room temperature over 2 h and stirred an additional 10 h. The mixture was 
poured into water (100 mL) and extracted with Et2O (3 x 100 mL). The combined 
organic layers were washed with brine (1 × 50 mL), dried over MgSO4, filtered through a 
pad of Celite, and concentrated in vacuo. The resulting β-nitro alcohol was used for the 
next step without further purification. 
Trifluoroacetic anhydride (4.2 mL, 30 mmol, 1 equiv) was added to a solution β-nitro 
alcohol in dichloromethane (30 mL) at -10 °C. The resulting solution was allowed to stir 
for 2 min, and then triethylamine (8.4 mL, 60 mmol, 2 equiv) was slowly added dropwise 
over 5 min and the reaction mixture was stirred for an additional 1 h at -10 °C. The 
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resulting mixture was poured into dichloromethane (100 mL) and washed with saturated 
aqueous NH4Cl solution (50 mL). The aqueous layer was back-extracted with 
dichloromethane (2 × 50 mL), and the combined organic layers were washed with brine 
(50 mL), dried (MgSO4), filtered, and concentrated in vacuo. The light yellow oil was 
purified by silica gel column chromatography (hexanes/EtOAc, 20/1) to afford the β-
nitro alkene. The obtained spectroscopic data were in accordance with those previously 
published.47 
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5.3.3. General procedure for the synthesis of β-amino nitroolefins49 
 
 
Triethylamine (0.7 mL, 5.0 mmol) was added to a solution of methoxylamine-HCl (0.42 
g, 5.0 mmol) in dimethylformamide (8 mL) at 0 °C. β-Nitroalkene (5.0 mmol) was then 
added and the resulting suspension was stirred at 0°C for 15 min and at rt for 5 min. The 
precipitate was removed by filtration and washed with a small amount of DMF. The 
combined filtrate was transferred into an addition funnel and was added dropwise to a 
potassium tert-butoxide (1.12 g, 10 mmol) solution in DMF (12 mL) at 0 °C. The cooling 
bath was then removed and the reaction mixture was stirred for 30 min at rt. The reaction 
was quenched with saturated aq. NH4Cl (30 mL). The solvents were distilled in vacuo 
and the residue was dissolved in CH2Cl2. The obtained organic phase was washed with 
water and brine, dried over MgSO4, filtered and concentrated in vacuo. The crude 
product was purified by chromatography on silica gel (CH2Cl2/ethyl acetate 6:1) to afford 
the desired β-amino nitroolefin. The obtained spectroscopic data were in accordance with 
those previously published.49 
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5.3.4. General procedure for the synthesis of β-acylamino nitroolefins50 
 
A stirred solution of β-amino nitrolefin (3.0 mmol) in toluene (10 mL) was cooled at 0 
°C and triethylamine (1.7 ml, 12.0 mmol, 4.0 equiv) followed by Ac2O (0.85 mL, 9.0 
mmol, 3.0 equiv) were added. The cooling bath was then removed and the solution was 
stirred at 45 °C overnight. The mixture was then concentrated under vacuum and the 
residue was purified by chromatography on silica gel (petroleum ether/ethyl acetate, 
80:20 to 50:50 or CH2Cl2/ethyl acetate 90:10) to afford the desired β-acylamino 
nitroolefin as a solid. The obtained spectroscopic data were in accord with those 
previously published.50 
 
(Z)-N-(2-nitro-1-phenylvinyl)acetamide (3a) 
Light yellow solid; Yield: 70%; 1H NMR (400 MHz, 
CDCl3) δ: 10.82 (s, 1H), 7.54-7.38 (m, 5H), 6.70 (s, 1H), 
2.25 (s, 3H).  
 
 
 
(Z)-N-(1-(4-methoxyphenyl)-2-nitrovinyl)acetamide (3b) 
Light yellow solid; Yield: 38%; 1H NMR (400 MHz, 
CDCl3) δ: 10.79 (s, 1H), 7.36-7.34 (m, 2H), 6.95-6.92 (m, 
2H), 6.73 (s, 1H), 3.85 (s, 3H), 2.26 (s, 3H).  
 
 
 
(Z)-N-(1-(4-chlorophenyl)-2-nitrovinyl)acetamide (3c) 
NO2
NH
O
3a
 
 
34 
 
Light yellow solid; Yield: 60%; 1H NMR (400 MHz, 
CDCl3) δ: 10.79 (s, 1H), 7.42-7.39 (m, 2H), 7.34-7.31 (m, 
2H), 6.67 (s, 1H), 2.27 (s, 3H). 
 
 
 
(Z)-N-(1-(4-fluorophenyl)-2-nitrovinyl)acetamide (3d) 
Light yellow solid; Yield: 48%; 1H NMR (400 MHz, 
CDCl3) δ: 10.80 (s, 1H), 7.40-7.37 (m, 2H), 7.14-7.10 (m, 
2H), 6.67 (s, 1H), 2.26 (s, 3H). 
 
 
 
(Z)-N-(1-(naphthalen-2-yl)-2-nitrovinyl)acetamide (3e) 
Light yellow solid; Yield: 80%; 1H NMR (400 MHz, 
CDCl3) δ: 10.90 (s, 1H), 7.89-7.85 (m, 4H), 7.59-7.52 (m, 
2H), 7.42 (dd, J = 8.5, 1.8 Hz, 1H), 6.82 (s, 1H), 2.28 (s, 
3H).  
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5.3.5. General procedure for the synthesis of β-t-butyloxycarbonylamino  
nitroolefins 
 
A stirred solution of β-amino nitroolefin (3.0 mmol) in CH2Cl2 (5 mL) was cooled at 0 
°C and di-t-butyl dicarbonate (0.78 g, 3.6 mmol, 1.2 equiv) followed by 4-dimethylamino 
pyridine (DMAP) (18 mg, 0.15 mmol, 0.05 equiv) were added. The cooling bath was 
then removed and the solution was stirred at rt for 15 min. The reaction was then 
quenched with water and extracted with CH2Cl2. The combined organic phases were 
dried over MgSO4, filtered concentrated in vacuo and the residue was purified by 
chromatography on silica gel (CH2Cl2/petroleum ether 3:1) to afford the desired β-t-
butyloxycarbonylamino nitroolefin. 
 
tert-Butyl (Z)-(2-nitro-1-phenylvinyl)carbamate (3f) 
Yield: 85%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.29 (s, 1H), 7.54-7.37 (m, 5H), 6.63 (s, 1H), 1.38 (s, 
9H); 13C NMR (100 MHz, CDCl3) : 150.7, 150.0, 132.0, 
130.8, 128.3, 127.6, 119.4, 83.1, 27.7; ESI MS(-) m/z: 263 
(M+-1); ESI MS(+) m/z: 287 (M++Na). 
 
tert-butyl (Z)-(2-nitro-1-(4-(trifluoromethyl)phenyl)vinyl)carbamate (3g) 
Yield: 80%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.29 (s, 1H), 7.70 (br d, J = 8.1 Hz, 2H), 7.53 (br d, J = 
8.1 Hz, 2H), 6.59 (s, 1H), 1.40 (s, 9H); 13C NMR (100 
MHz, CDCl3) : 150.0, 148.9, 135.7, 132.6 (q, J = 32.9 
Hz), 128.1, 125.5 (q, J = 3.8 Hz), 123.4 (q, J = 273 Hz), 
119.95, 83.8, 27.8; 19F NMR (376 MHz, CDCl3) : -62.95 
(s, 3F); ESI MS(+) m/z: 355 (M++Na). 
 
NO2
NH
O
O
3f
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tert-butyl (Z)-(2-nitro-1-(4-nitrophenyl)vinyl)carbamate (3h) 
Yield: 75%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.27 (s, 1H), 8.28 (br d, J = 8.9 Hz, 2H), 7.59 (br d, J = 
8.9 Hz, 2H), 6.60 (s, 1H), 1.40 (s, 9H); 13C NMR (100 
MHz, CDCl3) : 150.0, 149.0, 147.9, 138.4, 128.75, 123.6, 
120.0, 84.0, 27.8; ESI MS(+) m/z: 332 (M++Na) 
 
tert-butyl (Z)-(1-(furan-2-yl)-2-nitrovinyl)carbamate (3i) 
Yield: 80%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 9.98 (s, 1H), 7.60 (dd, J1 = 1.8, J2 = 0.8 Hz, 1H), 7.03 (s, 
1H), 6.96 (dd, J1 = 3.5, J2 = 0.8 Hz, 1H), 6.56 (dd, J1 = 3.5, 
J2 = 1.8 Hz, 1H), 1.48 (s, 9H); 
13C NMR (100 MHz, 
CDCl3) : 150.2, 145.9, 144.2, 138.8, 118.4, 116.7, 112.4, 
83.2, 27.8; ESI MS(+) m/z: 277 (M++Na). 
 
tert-butyl (Z)-(2-nitro-1-(p-tolyl)vinyl)carbamate (3j) 
Yield: 84%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.30 (s, 1H), 7.30 (br d, J = 8.4 Hz, 2H), 7.24 (br d, J = 
8.4 Hz, 2H), 6.64 (s, 1H), 2.41 (s, 3H), 1.41 (s, 9H); 13C 
NMR (100 MHz, CDCl3) : 151.0, 150.2, 141.5, 129.2, 
129.0, 127.7, 119.3, 83.1, 27.8, 21.5; ESI MS(+) m/z: 301 
(M++Na). 
 
tert-butyl (Z)-(2-nitro-1-(m-tolyl)vinyl)carbamate (3k) 
Yield: 72%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.26 (s, 1H), 7.34-7.30 (m, 2H), 7.23-7.18 (m, 2H), 6.63 
(s, 1H), 2.39 (s, 3H), 1.39 (s, 9H); 13C NMR (100 MHz, 
CDCl3) : 150.9, 150.1, 138.2, 132.0, 131.7, 128.3, 128.1, 
124.8, 119.4, 83.1, 27.7, 21.3; ESI MS(+) m/z: 301 
(M++Na). 
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tert-butyl (Z)-(2-nitro-1-(o-tolyl)vinyl)carbamate (3l) 
Yield: 70%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.59 (s, 1H), 7.37 (td, J1 = 7.4, J2 = 1.5 Hz, 1H), 7.29-
7.15 (m, 3H), 6.47 (s, 1H), 2.30 (s, 3H), 1.36 (s, 9H); 13C 
NMR (100 MHz, CDCl3) : 150.6, 149.5, 135.8, 131.6, 
130.0, 127.65, 125.8, 118.55, 83.1, 27.6, 19.2; ESI MS(+) 
m/z: 301 (M++Na). 
 
tert-butyl (Z)-(1-nitrohept-1-en-2-yl)carbamate (3m) 
Yield: 85%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.69 (s, 1H), 6.53 (s, 1H), 2.74-2.66 (m, 2H), 1.64-1.53 
(m, 2H), 1.51 (s, 9H), 1.39-1.31 (m, 4H), 0.93-0.86 (m, 
3H); 13C NMR (100 MHz, CDCl3) : 155.2, 150.1, 116.8, 
82.95, 31.3, 31.2, 28.1, 27.9, 22.2, 13.8; ESI MS(+) m/z: 
281 (M++Na). 
 
tert-butyl (Z)-(1-cyclohexyl-2-nitrovinyl)carbamate (3n) 
Yield: 82%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.84 (s, 1H), 6.62 (s, 1H), 3.62 (tt, J1 = 11.6, J2 = 2.8 
Hz, 1H), 1.99-1.89 (m, 2H), 1.89-1.70 (m, 3H), 1.51 (s, 
9H), 1.46-1.3 (m, 2H), 1.29-1.09 (m, 3H); 13C NMR (100 
MHz, CDCl3) : 160.0, 150.2, 115.8, 82.8, 37.6, 32.0, 28.0, 
26.2, 25.85; ESI MS(+) m/z: 253 (M++Na). 
 
tert-butyl (Z)-(4-methyl-1-nitropent-1-en-2-yl)carbamate (3o) 
Yield: 80%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.67 (s, 1H), 6.49 (s, 1H), 2.56 (d, J = 7.0 Hz, 2H), 
2.06-1.92 (m, 1H), 1.51 (s, 9H), 0.98 (d, J = 6.7 Hz, 6H); 
13C NMR (100 MHz, CDCl3) : 153.8, 150.2, 117.6, 82.9, 
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39.85, 27.9, 27.7, 22.2; ESI MS(+) m/z: 267 (M++Na). 
 
tert-butyl (Z)-(3-methyl-1-nitrobut-1-en-2-yl)carbamate (3p) 
Yield: 89%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.83 (s, 1H), 6.64 (s, 1H), 4.04-3.89 (m, 1H), 1.51 (s, 
9H), 1.19 (d, J = 9.5 Hz, 6H); 13C NMR (100 MHz, CDCl3) 
: 160.1, 150.2, 115.5, 82.9, 28.0, 27.8, 21.2; ESI MS(+) 
m/z: 253 (M++Na). 
 
tert-butyl (Z)-(1-nitrobut-1-en-2-yl)carbamate (3q) 
Yield: 50%; pale yellow oil, 1H NMR (400 MHz, CDCl3) δ: 
10.68 (s, 1H), 6.54 (s, 1H), 2.77 (q, J = 7.4 Hz, 2H), 1.50 
(s, 9H), 1.20 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) : 156.2, 150.1, 116.4, 82.95, 28.0, 24.75, 12.6; ESI 
MS(+) m/z: 239 (M++Na). 
 
tert-butyl (Z)-(2-nitro-1-phenylprop-1-en-1-yl)carbamate (3r) 
Yield: 68%; pale yellow solid, 1H NMR (400 MHz, CDCl3) 
δ: 10.79 (s, 1H), 7.60-7.42 (m, 3H), 7.30-7.25 (m, 2H), 1.93 
(s, 3H), 1.32 (s, 9H); ESI MS(+) m/z: 301 (M++Na). 
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5.4. Procedure for the Synthesis of Hantzsch ester 5b51  
 
A solution of paraformaldehyde (0.75 g, 25 mmol), tert-butyl acetoacetate (8.25 mL, 50 
mmol), aqueous NH4OH (15 mL of a 5 M solution, 75 mmol) in EtOH (20 mL) was 
heated at reflux (oil bath at 85°C) for 2 h. The mixture was then cooled to rt, poured into 
ice-water (75 mL) and extracted with Et2O (100 mL). The ether phase was washed 
successively with 10% aqueous solution of NaOH (50 mL), water (50 mL), 5% aqueous 
solution of HCl (50 mL) and water (50 mL). The ether solution was dried over MgSO4 
and filtered. The solvent was removed in vacuum to afford a yellow solid. The crude 
product was crystallized with MeOH (about 6-8 mL). To avoid oxidation of the 
dihydropyridine to the corresponding pyridine derivative, the solubilization of the crude 
product with MeOH must be quick and the recrystallization must be carry out under 
nitrogen atmosphere for not longer than 2 h. The title compound 5b was obtained as a 
pale yellow solid in a 32% yield. The reaction can be performed using a double amount 
of reagents using about 15 mL of MeOH for the crystallization affording 5b in 30% yield 
1H NMR (CDCl3, 400 MHz): δ = 4.96 (br s, 1H), 3.18 (s, 2H), 2.15 (s, 6H), 1.48 (s, 
18H). 
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5.5. General procedure for the synthesis of racemic β-amino  
nitroalkanes 4 
 
A stirred solution of 3 (0.1 mmol) in MeOH (0.5 mL, 0.2M) was cooled at 0 °C and 
NaBH4 (0.2 mmol, 8 mg, 2 equiv) was added in one portion. The cooling bath was then 
removed and the solution was stirred at rt for 15 min. The reaction was then quenched 
with saturated aq. NH4Cl (1 mL) and extracted with CH2Cl2 (2 x 3 ml). The combined 
organic phases were dried over MgSO4, filtered and concentrated in vacuo. The obtained 
product was purified by chromatography on silica gel (CH2Cl2/petroleum ether 3:1) if 
necessary or directly injected in CSP HPLC. 
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5.6. General Procedure for the Asymmetric Transfer Hydrogenation 
 
In a screw cap round bottom vial, to a stirred solution of 3 (0.15 mmol) in toluene (510 
μL, 0.3 M), catalyst 3 (3.9 mg, 0.0075 mmol, 0.05 equiv) and Hantzsch ester 5b (56 mg, 
0.18 mmol, 1.2 equiv) were added. The vial was saturated with nitrogen and closed with 
the cap. The reaction mixture was stirred for 14 h at 40 °C (Pg = Ac) or for 18 h at 40 °C 
(Pg = Boc, R1 = Aromatic) or for 24 h at 60 °C (Pg = Boc, R1 = Aliphatic). The resulting 
mixture was purified by column chromatography to afford product 4. 
 
(S)-N-(2-nitro-1-phenylethyl)acetamide (4a) 
The title compound 4a was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent ethyl acetate/petroleum ether 4:1). 
White solid; Yield 97%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel Chiralcel 
OJH column; n-hexane/2-propanol 9:1; 0.75 mL/min;  = 
254 nm; tR (major) = 35.3 min; tR (minor) = 42.8 min; ee 
>99%. [α]D
25 +73 (c 1.0, CH2Cl2); 
1H NMR (400 MHz, 
DMSO-d6) : 8.64 (d, J = 8.7 Hz, 1H), 7.40-7.33 (m, 3H), 
7.32-7.26 (m, 2H), 5.62-5.54 (m, 1H), 4.93 (dd, J1 = 5.3, J2 
= 13.1 Hz, 1H), 4.76 (dd, J1 = 9.6, J2 = 13.1 Hz, 1H), 1.85 
(s, 3H); 1H NMR (400 MHz, CDCl3) : 7.42-7.28 (m, 5H), 
6.33 (brs, 1H), 5.72-5.64 (m, 1H), 4.92 (dd, J1 = 13.0, J2 = 
6.4 Hz, 1H), 4.74 (dd, J1 = 13.0, J2 = 5.6 Hz, 1H), 2.05 (s, 
3H); 13C NMR (100 MHz, DMSO-d6) δ: 169.4, 138.6, 
129.1, 128.4, 127.6, 78.9, 51.1, 23.0; ESI MS(+) m/z: 231 
(M++Na). 
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(S)-N-(1-(4-methoxyphenyl)-2-nitroethyl)acetamide (4b) 
The title compound 4b was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent ethyl acetate/petroleum ether 4:1). 
White solid; Yield 91%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel Chiralcel 
OJH column; n-hexane/2-propanol 9:1; 0.75 mL/min,  = 
254 nm; tR (major) = 68.3 min; tR (minor) = 82.3 min; ee 
>99%. [α]D
25 +80 (c 1.0, CH2Cl2); 
1H NMR (400 MHz, 
DMSO-d6) : 8.54 (d, J = 8.7 Hz, 1H), 7.29 (br d, J = 8.7 
Hz, 2H), 6.90 (br d, J = 8.7 Hz, 2H), 5.49 (m, 1H), 4.86 
(dd, J1 = 5.6, J2 = 12.9 Hz, 1H), 4.75 (dd, J1 = 9.3, J2 = 12.9 
Hz, 1H), 3.71 (s, 3H), 1.82 (s, 3H); 13C NMR (100 MHz, 
DMSO-d6) δ: 169.2, 159.3, 130.5, 128.7, 114.5, 79.0, 55.6, 
50.6, 23.0; ESI MS(+) m/z: 261 (M++Na). 
 
(S)-N-(1-(4-chlorophenyl)-2-nitroethyl)acetamide (4c) 
The title compound 4c was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent ethyl acetate/petroleum ether 
2.5:1). White solid; Yield 90%. The enantiomeric excess 
was determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 8:2; 0.75 
mL/min,  = 254 nm; tR (major) = 5.8 min; tR (minor) = 9.1 
min; ee 97%. [α]D
25 +70 (c 1.0, CH2Cl2); 
1H NMR (400 
MHz, Acetone-d6) : 7.91 (br d, J = 7.2 Hz, 1H), 7.50 (br d, 
J = 8.5 Hz, 2H), 7.41 (br d, J = 8.5 Hz, 2H), 5.76-5.72 (br 
dd, J1 = J2 = 7.5 Hz, 1H), 4.99-4.90 (m, 2H), 1.93 (s, 3H); 
13C NMR (100 MHz, Acetone-d6) δ: 169.0, 137.2, 133.4, 
128.8, 128.7, 78.0, 50.7, 21.9; ESI MS(+) m/z: 265 
(M++Na). 
NO2
NH
O
4c
Cl
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(S)-N-(1-(4-fluorophenyl)-2-nitroethyl)acetamide (4d) 
The title compound 4d was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent ethyl acetate/petroleum ether 
2.5:1). White solid; Yield 94%. The enantiomeric excess 
was determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 9:1; 0.75 
mL/min,  = 254 nm; tR (major) = 10.7 min; tR (minor) = 
18.6 min; ee 97%. [α]D
25 +54.5 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 7.33-7.27 (m, 2H), 7.11-7.02 (m, 
2H), 6.45 (br d, J = 7.3 Hz, 1H), 5.64 (br dd, J1 = 13.5, J2 = 
6.2 Hz, 1H), 4.89 (dd, J1 = 13.0, J2 = 6.6 Hz, 1H), 4.70 (dd, 
J1 = 13.0, J2 = 5.5 Hz, 1H), 2.05 (s, 3H); 
13C NMR (101 
MHz, Acetone-d6) δ: 168.9, 167.4 (d, J = 244 Hz), 134.3 (d, 
J = 3.7 Hz), 129.1 (d, J= 8.1 Hz), 115.4 (d, J = 21 Hz), 
78.2, 50.6, 21.9; 19F NMR (376 MHz, CDCl3) : -115.77 
(br s, 1F); ESI MS(+) m/z: 249 (M++Na) 
 
(S)-N-(1-(naphthalen-2-yl)-2-nitroethyl)acetamide (4e) 
The title compound 4e was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent ethyl acetate/petroleum ether 
2.5:1). White solid; Yield 91%. The enantiomeric excess 
was determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 9:1; 0.75 
mL/min,  = 254 nm; tR (major) = 14.25 min; tR (minor) = 
24.8 min; ee 99%. [α]D
25 +112 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, Acetone-d6) : 8.01 (br d, J = 8.3 Hz, 1H), 7.98 
(br s, 1H), 7.92 (br d, J = 8.6 Hz, 1H), 7.91-7.88 (m, 2H), 
7.62 (br d, J1 = 8.6, J2 = 1.9 Hz, 1H), 7.55-7.50 (m, 2H), 
5.95 (br d, J1 = 8.0, J2 = 7.3 Hz, 1H), 5.05 (d, J = 7.2 Hz, 
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2H), 1.96 (s, 3H); 13C NMR (100 MHz, Acetone-d6) δ: 
169.1, 135.6, 133.3, 133.1, 128.6, 127.9, 127.6, 126.4, 
126.3, 125.95, 124.85, 78.3, 51.5, 22.0; ESI MS(+) m/z: 
281 (M++Na). 
tert-Butyl (S)-(2-nitro-1-phenylethyl)carbamate (4f) 
The title compound 4f was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent CH2Cl2/petroleum ether 6:1). 
White solid; Yield 90%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel Chiralcel 
OJH column; n-hexane/2-propanol 9:1; 0.75 mL/min,  = 
254 nm; tR (major) = 22.6 min; tR (minor) = 25.7 min; ee 
>99%. 
The same procedure was repeated using 2.0 mmol (532 mg) 
of 1f giving product 4f in 86% yield and >99%. ee. 
[α]D
25 +29 (c 1.0, CH2Cl2); 
1H NMR (400 MHz, CDCl3) : 
7.42-7.28 (m, 5H), 5.44-5.32 (m, 1H), 5.28 (br s, 1H), 4.91-
4.79 (m, 1H), 4.7 (dd, J1 = 12.6, J2 = 5.5 Hz, 1H); 
13C NMR 
(100 MHz, CDCl3) δ: 154.8, 136.9, 129.2, 128.7, 126.4, 
80.7, 78.9, 52.9, 28.3; MS(+) m/z: 289 (M++Na). 
tert-butyl (S)-(2-nitro-1-(4-(trifluoromethyl)phenyl)ethyl)carbamate (4g) 
The title compound 4g was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent CH2Cl2/petroleum ether 6:1). 
White solid; Yield 86%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 9:1; 0.75 
mL/min,  = 254 nm; tR (major) = 13.8 min; tR (minor) = 
21.1 min; ee >99%. [α]D
25 +18.5 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 7.65 (br d, J = 8.4 Hz, 2H), 7.45 (br 
d, J = 8.4 Hz, 2H), 5.52 (br s, 1H), 5.44 (br s, 1H), 4.86 (br 
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s, 1H), 4.79-4.69 (br m, 1H), 1.44 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ: 154.7, 141.0, 130.0 (q, J = 33 Hz), 126.8, 
126.1 (q, J = 3.7 Hz), 123.7 (q, J = 273 Hz), 81.1, 78.5, 
52.3, 28.2; 19F NMR (376 MHz, CDCl3) : -62.8; ESI 
MS(+) m/z: 357 (M++Na). 
 
tert-butyl (S)-(2-nitro-1-(4-nitrophenyl)ethyl)carbamate (4h) 
The title compound 4h was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent CH2Cl2/petroleum ether 5:1). 
White solid; Yield 93%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 9:1; 1.0 
mL/min;  = 254 nm; tR (major) = 26.6 min; tR (minor) = 
57.6 min; ee 96%. [α]D
25 +22.5 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 8.24 (br d, J = 8.9 Hz, 2H), 7.53 (br 
d, J = 8.9 Hz, 2H), 5.64 (br s, 1H), 5.49 (br s, 1H), 4.89 (br 
s, 1H), 4.83-4.72 (br m, 1H), 1.44 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ: 154.6, 147.9, 144.2, 127.4, 124.35, 81.3, 
78.3, 52.1, 28.3; ESI MS(+) m/z: 334 (M++Na). 
 
tert-butyl (S)-(1-(furan-2-yl)-2-nitroethyl)carbamate (4i) 
The title compound 4i was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent petroleum ether/ethyl acetate 
3.5:1). White solid; Yield 71%. The enantiomeric excess 
was determined by CSP HPLC analysis using a Daicel 
Chiralcel OJH column; n-hexane/2-propanol 9:1; 0.75 
mL/min,  = 254 nm; tR (major) = 20.8 min; tR (minor) = 
26.2 min; ee >99%. [α]D
25 +36.4 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 7.37 (dd, J1 = 1.9, J2 =0.8 Hz, 1H), 
6.34 (dd, J1 = 3.3, J2 =1.9 Hz, 1H), 6.31 (d t, J1 = 3.3, J2 
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=0.8 Hz, 1H), 5.51-5.41 (m, 1H), 5.30 (br s, 1H), 4.90-4.80 
(m, 1H), 4.72 (dd, J1 = 13.0, J2 =5.7 Hz, 1H), 1.45 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ: 154.6, 149.4, 143.0, 110.8, 
107.8, 80.9, 76.55, 47.2, 28.3; ESI MS(+) m/z: 279 
(M++Na). 
 
tert-butyl (Z)-(2-nitro-1-(p-tolyl)vinyl)carbamate (4j) 
The title compound 4j was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent petroleum ether/ethyl acetate 7:1). 
White solid; Yield 86%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel Chiralcel 
OJH column; n-hexane/2-propanol 9:1; 0.75 mL/min,  = 
254 nm; tR (major) = 17.2 min; tR (minor) = 23.4 min; ee 
97%. [α]D
25 +35.7 (c 1.0, CH2Cl2); 
1H NMR (400 MHz, 
CDCl3) : 7.21-7.15 (m, 4H), 7.38-7.25 (m, 2H), 4.82 (br s, 
1H), 4.67 (br dd, J1 = 12.3, J2 =5.2 Hz, 1H), 2.33 (s, 3H), 
1.43 (s, 9H);  13C NMR (100 MHz, CDCl3) δ: 154.75, 
138.5, 133.9, 129.9, 126.1, 80.6, 78.9, 52.6, 28.2, 21.1; ESI 
MS(+) m/z: 303 (M++Na). 
tert-butyl (S)-(2-nitro-1-(m-tolyl)ethyl)carbamate (4k) 
The title compound 4k was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent petroleum ether/ethyl acetate 7:1). 
White solid; Yield 75%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak AS column; n-hexane/2-propanol 9:1; 1.0 
mL/min,  = 254 nm; tR (major) = 10.6 min; tR (minor) = 
15.7 min; ee >99%. [α]D
25 +31.6 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 7.29-7.23 (m, 1H), 7.16-7.07 (m, 
3H), 5.38-5.24 (m, 2H), 4.82 (br s, 1H), 4.68 ((br dd, J1 = 
12.4, J2 =5.5 Hz, 1H), 2.35 (s, 3H), 1.44 (s, 9H); 
13C NMR 
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(100 MHz, CDCl3) δ: 154.7, 138.95, 136.8, 129.4, 129.0, 
127.1, 123.25, 80.6, 78.9, 52.8, 28.2, 21.4; ESI MS(+) m/z: 
303 (M++Na). 
 
tert-butyl (S)-(2-nitro-1-(o-tolyl)ethyl)carbamate (4l) 
The title compound 4l was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent petroleum ether/ethyl acetate 7:1). 
White solid; Yield 40% (conversion 50%). The 
enantiomeric excess was determined by CSP HPLC 
analysis using a Daicel Chiralcel OJH column; n-hexane/2-
propanol 9:1; 0.75 mL/min,  = 254 nm; tR (major) = 28.3 
min; tR (minor) = 19.0 min; ee 98% or Daicel Chiralcel OD 
column; n-hexane/2-propanol 9:1; 1.0 mL/min,  = 254 nm; 
tR (major) = 43.8 min; tR (minor) = 21.5 min. [α]D
25 +43.5 
(c 1.0, CH2Cl2); 
1H NMR (400 MHz, CDCl3) : 7.25-7.19 
(m, 4H), 5.65 (br dd, J1 = J2 = 6.9 Hz, 1H), 5.11 (br d, J = 
7.5 Hz, 1H), 4.76 (br s, 1H), 4.71-4.62 (m, 1H), 2.45 (s, 
3H), 1.42 (s, 9H); 13C NMR (100 MHz, CDCl3) δ: 154.5, 
135.9, 135.2, 131.3, 128.6, 126.8, 124.9, 80.6, 77.9, 49.31, 
28.2, 19.1; ESI MS(+) m/z: 303 (M++Na). 
 
tert-butyl (S)-(1-nitroheptan-2-yl)carbamate (4m) 
The title compound 4m was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent petroleum ether/ethyl acetate 7:1). 
White solid; Yield 91%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 95:5; 0.75 
mL/min,  = 254 nm; tR (major) = 13.4 min; tR (minor) = 
12.5 min; ee 98%. [α]D
25 -28.6 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 4.82 (br d, J = 7.5 Hz, 1 H), 4.52 (br 
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d, J = 4.7 Hz, 2H), 4.15-4.03 (m, 1H), 1.61-1.50 (m, 2H), 
1.44 (s, 9H), 1.41-1.23 (m, 6H), 0.88 (br t, J = 6.8 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ: 155.1, 80.1, 78.3, 49.2, 
31.7, 31.4, 28.25, 25.5, 22.4, 13.8; MS(+) m/z: 283 
(M++Na). 
 
tert-butyl (S)-(1-cyclohexyl-2-nitroethyl)carbamate (4n) 
The title compound 4n was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent petroleum ether/ethyl acetate 8:1). 
White solid; Yield 88%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 95:5; 0.75 
mL/min,  = 254 nm; tR (major) = 19.2 min; tR (minor) = 
14.1 min; ee 98%. [α]D
25 -15.5 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 4.87 (br d, J = 9.2 Hz, 1H), 4.62-4.48 
(m, 2H), 4.00-3.90 (br s, 1H), 1.85-1.47 (m, 6H), 1.43 (s, 
9H), 1.30-0.93 (m, 5H); 13C NMR (100 MHz, CDCl3) δ: 
155.3, 80.0, 76.7, 53.9, 39.4, 29.8, 29.0, 28.25, 25.9, 25.7; 
ESI MS(+) m/z: 295 (M++Na). 
 
tert-butyl (S)-(4-methyl-1-nitropentan-2-yl)carbamate 4(o) 
The title compound 4o was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent CH2Cl2/petroleum ether 6:1). 
White solid; Yield 60%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 95:5; 0.75 
mL/min;  = 254 nm. tR (major) = 15.3 min; tR (minor) = 
12.3 min; ee 96%. [α]D
25 -40 (c 1.0, CH2Cl2); 
1H NMR (400 
MHz, CDCl3) : 4.79 (br s, 1H), 4.53 (br d, 2H), 4.26-4.13 
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(m, 1H), 1.80-1.64 (m, 1H), 1.59-1.30 (m, 2H), 1.46 (s, 
9H), 0.96 (d, J = 6.6 Hz, 3H), 0.95 (d, J = 6.5 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ:155.0, 80.2, 78.7, 47.4, 40.6, 
28.3, 24.8, 22.8, 21.9; ESI MS(+) m/z: 269 (M++Na). 
 
tert-butyl (S)-(3-methyl-1-nitrobutan-2-yl)carbamate (4p) 
The title compound 4p was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent petroleum ether/ethyl acetate 6:1). 
White solid; Yield 91%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 95:5; 0.75 
mL/min,  = 254 nm; tR (major) = 21.7 min; tR (minor) = 
13.6 min; ee 93%. [α]D
25 -21.5 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 4.86 (br d, J = 8.2 Hz, 1H), 4.61-4.49 
(m, 2H), 4.01-3.91 (br s, 1H), 1.95-1.83 (m, 1H), 1.44 (s, 
9H), 1.01 (d, J1 = 6.8, 3H), 0.99 (d, J1 = 6.8, 3H); 
13C NMR 
(100 MHz, CDCl3) δ: 155.25, 80.1, 76.96, 54.7, 30.0, 28.3, 
19.4, 18.55; ESI MS(+) m/z: 255 (M++Na). 
 
tert-butyl (S)-(1-nitrobutan-2-yl)carbamate (4q) 
The title compound 4q was prepared according to the 
general procedure and purified by silica gel 
chromatography (eluent CH2Cl2/petroleum ether 6:1). 
White solid; Yield 92%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 95:5; 0.75 
mL/min,  = 234 nm; tR (major) = 16.5 min; tR (minor) = 
14.0 min; ee 97%. [α]D
25 -21.5 (c 1.0, CH2Cl2); 
1H NMR 
(400 MHz, CDCl3) : 4.81 (br s, 1H), 4.60-4.48 (m, 2H), 
4.09-3.96 (m, 1H), 1.68-1.54 (m, 2H), 1.44 (s, 9H), 1.00 (t, 
J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 155.1, 
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80.1, 78.0, 50.6, 28.2, 25.0, 10.4; ESI MS(+) m/z: 241 
(M++Na). 
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tert-butyl (1S,2R)-2-nitro-1-phenylpropylcarbamate and tert-butyl (1S,2S)-2-nitro-
1-phenylpropylcarbamate (4r) 
A 2:1 mixture of (1S,2R)-4r and (1S,2S)-4r was obtained 
following the general procedure and was purified by silica 
gel chromatography (eluent CH2Cl2/petroleum ether 5:1). 
White solid; Yield 88%. The enantiomeric excess was 
determined by CSP HPLC analysis using a Daicel 
Chiralpak ADH column; n-hexane/2-propanol 95:5; 1.0 
mL/min,  = 254 nm; (1S,2R)-4r: tR (major) = 19.9 min; tR 
(minor) = 22.8 min; (1S,2S)-4r: tR (major) = 33.6 min; tR 
(minor) = 26.86 min. The relative and the absolute 
configurations were determined by comparison with 
literature data. 52 
1H NMR (400 MHz, CDCl3) : 7.40-720 (m, 5Hmaj+5Hmin), 
5.60 (br s, 1Hmin), 5.35 (br s, 1Hmaj), 5.20 (dd, J1 = 9.0, J2 = 
5.8 Hz, 1Hmaj), 5.11 (brs, 1Hmin), 4.93 (br m, 1Hmaj+1Hmin), 
1.54 (brs, 3Hmin), 1.53 (d, J = 6.9 Hz, 3Hmaj), 1.43-1.42 (br 
s, 9Hmaj+9Hmin). 
The obtained spectroscopic data were in accordance with 
those previously published.52,53,54 
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5.7. Determination of the absolute configuration of the β-amino  
nitroalkanes 
The absolute configuration of products 4 was determined to be S by comparison with 
literature data (CSP-HPLC retention time and optical rotation [α]D value) for compound 
4a,39 4f,4030,40 4l,55 4n30,40 and 4o40.  
 
 
 
 
[α]D
25 +73 (c 1.0, CH2Cl2); 
Lit [α]D
20 = -69.20 (c = 0.5, CH2Cl2), 99% ee (R) 
 
 
 
[α]D
25 +29 (c 1.0, CH2Cl2); 
Lit [α]D
25 = -20.1(c 1.0, CHCl3), 91% ee (R) 
 
 
 
[α]D
25 +43.5 (c 1.0, CH2Cl2); 
Lit [α]D
25 = - 47.0 (c 0.5, CHCl3); 99% ee (R) 
 
 
 
[α]D
25 -15.5 (c 1.0, CH2Cl2); 
Lit [α]D
25 = +24 (c 1.0, CHCl3), 98% ee (R) 
 
 
 
[α]D
25 -40 (c 1.0, CH2Cl2); 
Lit [α]D
25 = +26.4 (c 1.0, CHCl3), 97 % ee (R) 
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5.8. 1H-NMR spectra of products 4a and 4f
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